Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
Figure 2
Belinostat metabolism pathway in human plasma with glucuronidation of belinostat as the dominant metabolism.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Belinostat metabolism pathway in human plasma with glucuronidation of belinostat as the dominant metabolism.